• Vatn Systems

  Participated · Series A · Dec 2025

  Founded in 2023 in Rhode Island by maritime practitioners and defense engineers, Vatn Systems is building scalable fleets of autonomous underwater vehicles for the U.S. military, allied governments, and civilian customers. Its flagship platforms, the Skelmir S6 and Skelmir S12, combine a plug-and-play payload architecture with INStinct, the company’s proprietary inertial navigation system that provides GPS-denied guidance at a fraction of traditional costs. The vehicles support distributed sensing, ISR, mine countermeasures, electronic warfare, and other emerging undersea missions, and can be re-configured for offshore energy, port security, and environmental monitoring in days rather than months. Throughout 2025 the company delivered AUVs to U.S. government customers, ran successful open-water demonstrations, and ramped production capacity to meet growing demand. Vatn positions itself as a future “underwater defense prime” by offering attritable, mass-deployable systems that align with shifting naval doctrines. Commercially, the same low-cost autonomy unlocks persistent coastal infrastructure monitoring and scientific research opportunities. The recent capital infusion is intended to accelerate production scaling and broaden mission profiles for both defense and civilian markets.

• HavocAI

  Participated · Equity · Oct 2025

  Havoc develops an all-domain collaborative autonomy stack and a software-defined hardware approach that enables heterogeneous autonomous assets to sense, decide, and act together across sea, air, and land. The company reports more than 25,000 hours of autonomous testing and deployments and has collected over 200 billion data points from operations to iterate its field-tested autonomy stack. Havoc has built and deployed 100+ autonomous surface vessels (ASVs) globally, with 40+ mission-ready today and 30+ vessels delivered to the U.S. Department of Defense. It has made strategic acquisitions (Mavrik and Teleo) to expand into air and land domains and maintains partnerships with defense primes such as Leidos, Lockheed Martin, and SAIC as well as shipbuilders and additive manufacturers. Havoc has grown to over 200 employees, opened new offices in Austin and San Diego, and expanded maritime production in Rhode Island. The company highlights award recognition, SBIR awards, and selection to industry challenges as validation while positioning itself to scale deployments and production to meet defense and commercial demand.

• Hone Health

  Participated · Series A · Jan 2025

  Hone Health operates an online clinic focused on preventative and proactive longevity care, combining telemedicine, at‑home and in‑person lab testing, and physician‑directed treatment plans. Founded in 2020, the platform emphasizes hormone optimization and delivers tailored protocols based on 40+ biomarkers, with plans starting at $129/month. The company reports it has crossed 300,000 patients tested and 55,000 patients treated. Hone runs a proprietary EMR and patient data engine that has collected an extensive hormone dataset and plans to expand insights into menopause, thyroid, and longevity care. The business aims to integrate medications, supplements, lifestyle guidance, and community support to improve healthspan while prioritizing regulatory compliance and patient safety. Hone recently acquired ivee to introduce in‑home healthcare services, enabling clinicians to deliver personalized care directly in patients’ homes.

• DreamBig Semiconductor

  Participated · Series B · Jul 2024

  DreamBig Semiconductor develops a chiplet platform that enables modular semiconductor solutions centered on its Chiplet Hub™ and Platform Chiplets. The company offers high-performance accelerator platforms and networking chiplets targeting LLMs, generative AI, data centers, edge computing, and automotive applications. Key capabilities include universal architecture support for CPU, AI, accelerator, I/O, networking, and memory chiplets within a unified platform and a Memory-First Architecture providing direct access to 3D stacked HBM, DDR, CXL, and SSD memory tiers. Additional technical features highlighted are fully associative hardware acceleration for cache/memory management (FLC Technology Group), DMA hardware for efficient transfers, a virtual PCIe/CXL switch, Ethernet/UEC RDMA hardware, and multi‑gigabit, low‑power CAM for 800Gbps match/action processing. The company intends to use the recently raised funds to accelerate development and commercialization of products built on its Chiplet Hub and Platform Chiplets. Led by CEO Sohail Syed, DreamBig positions itself to scale processor, accelerator, and networking chiplets across heterogeneous memory and compute domains.

• Lumen

  Participated · Series B · Dec 2022

  Lumen developed a handheld hardware device with a built-in CO2 sensor that determines metabolic fuel usage (whether the body is burning carbs or fat) and pairs with a smartphone app to provide personalized food, exercise and sleep recommendations. The device, which resembles a vape, is sold starting at about $250 with higher-priced personalized plans available. Lumen says the hardware replicates metabolic measurements that previously required expensive lab equipment and enables more frequent, at-home data collection. The company reports two million monthly metabolic measurements are taken using its devices. Co-founder and chief scientist Merav Mor said the product also opens new possibilities for research protocols by making data collection easier and more scalable. Lumen plans to use new funding to support business growth and new research. Lumen produces a pocket-sized device that measures metabolic gases in a single breath and uses a companion app to translate readings into daily personalized meal plans. The founders, Merav and Michal Mor, are both PhDs in physiology and cell biology; CEO Daniel Tal is also a co-founder. After four years of R&D they developed a method to measure respiratory quotient (RQ) in under three minutes; the technology is patent-pending and Frog design helped with product design. The company has raised $7 million over the past four and a half years and recently exceeded $1 million on an Indiegogo campaign. More than 300 beta users have averaged a 6.8 lb weight loss within the first 30 days of using the device. Lumen differentiates itself from competitors by requiring no cartridges, filters, or replacements and offering a free app.

No current team members are available.